Author

Ryuya Iida

Institute of Medical Science, The University of Tokyo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Kazumasa Yokoyama· 1 shared Kazuto YoshimiiD· 1 shared Kohei TakeshitaiD· 1 shared Koji TamadaiD· 1 shared Shôji Watanabe· 1 shared Tomoaki FujiiiD· 1 shared Tomoji MashimoiD· 1 shared Tsubasa Obo· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Kazumasa Yokoyama

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Efficient gene disruption with CRISPR-Cas3 in human T cells

Tomoaki Fujii, Yukimi Sakoda, Kazuto Yoshimi, Kohei Takeshita, Shôji Watanabe, Ryuya Iida, Tsubasa Obo, Kazumasa Yokoyama, Koji Tamada, Tomoji Mashimo

This study demonstrates that CRISPR-Cas3 can efficiently and safely disrupt genes in human T cells, reducing off-target effects and alloreactivity while maintaining cytotoxicity.

NAR Cancer · Mar 26, 2026Peer-reviewedCancer Biology